chartexchange

VRCA
Verrica Pharmaceuticals Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:58:32 PM EST
2.87USD-8.599%(-0.27)42,853
After-hoursNov 18, 2026 4:12:30 PM EST
2.85USD-0.697%(-0.02)
Loading…
Loading…
Healthcare
Biotechnology
HQ
West Chester, PA, USA
Previous Close
$3.14
Beta
2.28
52-Week High
$9.82 2025-11-28
52-Week Low
$2.77 2026-11-17
SMA 50
$3.98
SMA 200
$5.36
Avg. Vol 10D
72,641
Avg. Vol 30D
60,431
Avg. Vol 90D
63,449
Relative Vol
0.74
8.76M
0.6300%
Jul 25, 2025 · 1-for-10 (reverse)
VRCA Profile

verrica pharmaceuticals inc., a clinical stage medical dermatology company, develops and commercializes dermatological treatments in the united states. the company's lead product candidate include vp-102 that is in phase iii clinical trial for the treatment of molluscum contagiosum; in phase ii clinical trial for the treatment of common warts; and completed phase i clinical trial for the treatment of genital warts. it is also developing cantharidin-based product candidate, vp-103 for the treatment of plantar warts. the company has a license agreement with lytix biopharma as to develop and commercialize ltx-315 for dermatologic oncology indications. verrica pharmaceuticals inc. was founded in 2013 and is headquartered in west chester, pennsylvania.

VRCA Performance
PeriodPriceDateChangeBeta
1W3.912026-11-11-25.83%3.237
1M3.442026-10-19-15.70%3.226
3M4.682026-08-18-38.03%2.385
6M5.872026-05-18-50.60%1.551
1Y3.832025-11-18-24.28%2.280
2Y8.882024-11-18-67.35%—
5Y112.602021-11-18-97.42%1.043
VRCA Stock Summary

Verrica Pharmaceuticals Inc. Common Stock (NASDAQ:VRCA) stock price today is $2.90, and today's volume is 44,476. VRCA is down 7.643% today. The 30 day average volume is 60,431. VRCA market cap is $49.82M with 17.18M shares outstanding.